newsfilter
← Latest News
Business Wire·

Glancy Binkow & Goldberg LLP Encourages Investors of Achillion Pharmaceuticals, Inc. with Losses of $250,000 or More to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Achillion Pharmaceuticals, Inc. (“Achillion” or the “Company”) (NASDAQ:ACHN) concerning possible violations of federal securities laws. Investors with losses of $250,000 or more are encouraged to contact the firm for more information.